Martin Shkreli Fraud Trial Begins Today

Jan 20, 2023:

https://thehill.com/policy/healthcare/3821657-ftc-asks-court-to-hold-pharma-bro-martin-shkreli-in-contempt

Mar 9, 2018:

https://www.usatoday.com/story/money/2018/03/09/martin-shkreli-sentenced-7-years-prison/359705002

Mar 5, 2018:

https://www.usatoday.com/story/money/2018/03/05/pharma-bro-martin-shkreli-forfeit-nearly-7-4-m-assets-he-faces-sentencing-foer-including-rare-wu-tan/396080002

Feb 28, 2018:

In a letter to Brooklyn federal court Judge Kiyo Matsumoto, Shkreli asked the judge for leniency.

Sep 14, 2017:

Aug 4, 2017:

After five days of deliberation a jury found Martin Shkreli guilty on three of the eight counts of fraud he was charged with.

Jul 30, 2017:

Jun 26, 2017:

The trial of Martin Shkreli begins today. Shkreli faces charges of securities fraud, wire fraud, and conspiracy for allegedly mismanaging investor money and running a Ponzi scheme with funds received by his investment companies Elea Capital, MSMB Capital, MSMB Healthcare, and while he was CEO of Retrophin, a pharmaceutical company he founded in 2011.

Apr 19, 2017:

In Brooklyn, New York, U.S. District Court Judge Kiyo Matsumoto ruled that Shkreli will be tried separately from Evan Greebel.

Greebel is expected to testify that Shkreli lied to him. Shkreli is expected to testify that he acted based on the legal advice of Greebel.

Dec 17, 2015:

Martin Shkreli was arrested and indicted on charges of securities fraud and was freed on a $5 million bond. His lawyer, Evan Greebel, was also charged and was freed on a $1 million bond.

Sep 20, 2015:

Turing Pharmaceuticals, a company founded by Martin Shkreli and of which he is the executive officer, raised the price of a drug named Daraprim from $13.50 a tablet to $750 a tablet. Daraprim is used to treat a life-threatening parasitic infection.

Regarding the price increase, Shkreli said the following:

This isn't the greedy drug company trying to gouge patients, it is us trying to stay in business...This is still one of the smallest pharmaceutical products in the world. It really doesn't make sense to get any criticism for this.

Source:

Pollack, Andrew. (September 20, 2015). "Drug Goes From $13.50 a Tablet to $750, Overnight". The New York Times. Retrieved 2017-07-23.

More:

Leave a Reply

Your email address will not be published. Required fields are marked *